Davis Jennifer L. 4

4 · PROCTER & GAMBLE Co · Filed Aug 7, 2025

Form 4

Period: 2025-08-07

CEO - Health Care

Transactions

Award
Restricted Stock Units
2025-05-15+23.872→ 203.758 total
→ Common Stock (23.872 underlying)
Award
Restricted Stock Units
2025-08-07+1,026→ 1,026 total
→ Common Stock (1,026 underlying)
Award
Series A Preferred Stock
2025-07-14+0.632→ 4,351.744 total(indirect: By Trust)
→ Common Stock (0.632 underlying)

Holdings

Footnotes (7)

[F1]Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
[F2]Reflects adjustment to PST through July 14, 2025.
[F3]Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
[F4]These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
[F5]Higher of $6.82 (adjusted for 2-for-1 stock split effective May 21, 2004) or market price of Common Stock.
[F6]Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price.
[F7]Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2025.

Documents

1 file